Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 92, Issue , 2015, Pages 120-129

  England, Christopher G ^a   Miller, M Clarke ^b   Kuttan, Ashani ^a   Trent, John O ^a   Frieboes, Hermann B ^a,c,d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF NORTH GEORGIA   (United States)

^c University of Louisville   (United States)

^d Dept of Medicine University of Louisville ^*  (United States)

Author keywords

Cisplatin; Drug release kinetics; Drug release modeling; Nanotherapy; Paclitaxel

Indexed keywords

CISPLATIN; COLLOIDAL GOLD; GOLD NANOPARTICLE; HIGH DENSITY LIPOPROTEIN; PACLITAXEL; PHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; GOLD; HEXADECANETHIOL; METAL NANOPARTICLE; THIOL DERIVATIVE;

ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG RELEASE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; KINETICS; LUNG CANCER CELL LINE; MATHEMATICAL MODEL; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; SURFACE PROPERTY; TISSUE STRUCTURE; ZETA POTENTIAL; CHEMICAL MODEL; CHEMICAL PHENOMENA; CHEMISTRY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CISPLATIN; DELAYED-ACTION PREPARATIONS; DRUG LIBERATION; GOLD; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; LIPOPROTEINS, HDL; METAL NANOPARTICLES; MODELS, CHEMICAL; PACLITAXEL; PHOSPHATIDYLCHOLINES; SULFHYDRYL COMPOUNDS;

EID: 84925258208     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.02.017     Document Type: Article

References (62)

1. A. Clegg, D.A. Scott, P. Hewitson, M. Sidhu, and N. Waugh Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review Thorax 57 1 2002 20 28
2. H.S. Oberoi, N.V. Nukolova, A.V. Kabanov, and T.K. Bronich Nanocarriers for delivery of platinum anticancer drugs Adv. Drug. Deliver. Rev. 65 13-14 2013 1667 1685
3. U.-M. Ohndorf, M.A. Rould, Q. He, C.O. Pabo, and S.J. Lippard Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins Nature 399 6737 1999 708 712
4. S.B. Horwitz Taxol (paclitaxel): mechanisms of action Ann. Oncol. 5 Suppl. 6 1994 S3 S6
5. E.K. Rowinsky, E.A. Eisenhauer, V. Chaudhry, S.G. Arbuck, and R.C. Donehower Clinical toxicities encountered with paclitaxel (Taxol) Semin. Oncol. 20 4 Suppl. 3 1993 1 15
6. P. Ma, and R.J. Mumper Paclitaxel nano-delivery systems: a comprehensive review J. Nanomed. Nanotechnol. 4 2 2013 1000164
7. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer. 37 13 2001 1590 1598
8. S. Jain, D.G. Hirst, and J.M. O'Sullivan Gold nanoparticles as novel agents for cancer therapy Brit. J. Radiol. 85 1010 2012 101 113
9. H. Chen, Y. Gu, Y. Hu, and Z. Qian Characterization of pH- and temperature-sensitive hydrogel nanoparticles for controlled drug release J. Pharm. Sci. Technol. 61 4 2007 303 313
10. J.V. Jokerst, T. Lobovkina, R.N. Zare, and S.S. Gambhir Nanoparticle PEGylation for imaging and therapy Nanomed. (London, England) 6 4 2011 715 728
11. J.W. Nichols, and Y.H. Bae Odyssey of a cancer nanoparticle: from injection site to site of action Nano Today 7 6 2012 606 618
12. M. Longmire, P.L. Choyke, and H. Kobayashi Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine-UK 3 5 2008 703 717
13. D.N. Heo, D.H. Yang, H.J. Moon, J.B. Lee, M.S. Bae, and S.C. Lee Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy Biomaterials 33 3 2012 856 866
14. J.R. Hwu, Y.S. Lin, T. Josephrajan, M.H. Hsu, F.Y. Cheng, and C.S. Yeh Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles J. Am. Chem. Soc. 131 1 2009 66 68 January 14
15. Y. Ding, Y.-Y. Zhou, H. Chen, D.-D. Geng, D.-Y. Wu, and J. Hong The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles Biomaterials 34 38 2013 10217 10227
16. 2S nanoparticles for potential cancer therapy: cytotoxicity, in vitro carcinogenicity, and cellular uptake J. Biomed. Mater. Res. A 85 3 2008 787 796
17. S. Sanchez-Paradinas, M. Perez-Andres, M.J. Almendral-Parra, E. Rodriguez-Fernandez, A. Millan, and F. Palacio Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles J. Inorganic Biochem. 131 2014 8 11
18. Y. Shi, J. Goodisman, and J.C. Dabrowiak Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin Inorg. Chem. 52 16 2013 9418 9426
19. D.H. Tsai, T.J. Cho, S.R. Elzey, J.C. Gigault, and V.A. Hackley Quantitative analysis of dendron-conjugated cisplatin-complexed gold nanoparticles using scanning particle mobility mass spectrometry Nanoscale 5 12 2013 5390 5395
20. J. Comenge, C. Sotelo, F. Romero, O. Gallego, A. Barnadas, and T.G. Parada Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin PloS One 7 10 2012 e47562
21. C. Tomuleasa, O. Soritau, A. Orza, M. Dudea, B. Petrushev, and O. Mosteanu Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells J. Gastrointest. Liver Dis. 21 2 2012 187 196
22. G.E. Craig, S.D. Brown, D.A. Lamprou, D. Graham, and N.J. Wheate Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? Inorg. Chem. 51 6 2012 3490 3497
23. J. Comenge, F.M. Romero, C. Sotelo, F. Dominguez, and V. Puntes Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin J. Control. Release 148 1 2010 e31 e32
24. T. Panczyk, A. Jagusiak, G. Pastorin, W.H. Ang, and J. Narkiewicz-Michalek Molecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles J. Phys. Chem. 117 33 2013 17327 17336
25. S. Likhitkar, and A.K. Bajpai Magnetically controlled release of cisplatin from superparamagnetic starch nanoparticles Carbohyd Polym. 87 1 2012 300 308
26. C.G. England, T. Priest, G. Zhang, X. Sun, D.N. Patel, and L.R. McNally Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles Int. J. Nanomed. 8 2013 3603 3617
27. M. Barzegar-Jalali, K. Adibkia, H. Valizadeh, M.R. Shadbad, A. Nokhodchi, and Y. Omidi Kinetic analysis of drug release from nanoparticles J. Pharm. Pharm. Sci. 11 1 2008 167 177
28. G. Frens Controlled nucleation for the regulation of the particle size in monodisperse gold solutions Nature Phys. Sci. 241 1973 20 22
29. S. Huo, H. Ma, K. Huang, J. Liu, T. Wei, S. Jin, S. He, and X.J. Liang Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors Cancer Res. 73 1 2013 319 330
30. C.D. Bain, H.A. Biebuych, and G.M. Whitesides Comparison of self-assembled monolayers on gold: coadsorption of thiols and disulfides Langmuir 5 1989 723 727
31. H. Häkkinen The gold-sulfur interface at the nanoscale Nat. Chem. 4 6 2012 443 455
32. C. Fonseca, S. Simoes, and R. Gaspar Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity J. Control. Release 83 2 2002 273 286
33. A. Semalty, M. Semalty, D. Singh, and M.S.M. Rawat Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery J. Incl. Phenom. Macrocycl. Chem. 67 3-4 2010 253 260
34. S. Dash, P.N. Murthy, L. Nath, and P. Chowdhury Kinetic modeling on drug release from controlled drug delivery systems Acta Pol. Pharmaceut. 67 3 2010 217 223
35. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
36. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharmaceut. 15 1 1983 25 35
37. R. Bettini, P.L. Catellani, P. Santi, G. Massimo, N.A. Peppas, and P. Colombo Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate J. Control. Release 70 3 2001 383 391
38. J. Kimling, M. Maier, B. Okenve, V. Kotaidis, H. Ballot, and A. Plech Turkevich method for gold nanoparticle synthesis revisited J. Phys. Chem. 110 32 2006 15700 15707
39. E. Suleymanoglu The use of infrared spectroscopy for following drug-membrane interactions: probing paclitaxel (Taxol)-cell phospholipid surface recognition Electr. J. Biomed. 3 2009 19 35
40. D. Krilov, M. Balarin, M. Kosovic, O. Gamulin, and J. Brnjas-Kraljevic FT-IR spectroscopy of lipoproteins-a comparative study Spectrochim. Acta A Mol. Biomol. Spectrosc. 73 4 2009 701 706
41. J. Siepmann, and N.A. Peppas Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv. Drug Deliver. Rev. 64 2012 163 174 Supplement (0)
42. H. Takahashi, Y. Niidome, T. Niidome, K. Kaneko, H. Kawasaki, and S. Yamada Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity Langmuir 22 1 2006 2 5
43. J.T. Jiang, P. Nilsson-Ehle, and N. Xu Influence of liver cancer on lipid and lipoprotein metabolism Lipids Health Dis. 5 2006
44. J.B. Hall, M.A. Dobrovolskaia, A.K. Patri, and S.E. McNeil Characterization of nanoparticles for therapeutics Nanomed. (London, England) 2 6 2007 789 803
45. M. Benkovicova, K. Vegso, P. Siffalovic, M. Jergel, S. Luby, and E. Majkova Preparation of gold nanoparticles for plasmonic applications Thin Solid Films. 543 2013 138 141
46. A. Bootz, V. Vogel, D. Schubert, and J. Kreuter Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles Eur. J. Pharm. Biopharm. 57 2 2004 369 375
47. T. Wutikhun, O. Ketchart, T. Treetong, B. Jaidee, C. Warin, and S. Supaka Measurement and compare particle size determined by DLS, AFM and SEM J. Micros. Soc. Thailand 5 1-2 2012 38 41
48. K. Gándola, S.E. Pérez, P.E. Irene, A.I. Sotelo, J.G. Miquet, G.R. Corradi, A.M. Carlucci, and L. Gonzalez Mitogenic effects of phosphatidylcholine nanoparticles on MCF-7 breast cancer cells BioMed Res. Int. 1 2014 (2014)
49. G. Blume, and G. Cevc Molecular mechanism of the lipid vesicle longevity invivo Biochimica et Biophysica Acta 1146 2 1993 157 168
50. K. Xiao, Y. Li, J. Luo, J.S. Lee, W. Xiao, and A.M. Gonik The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles Biomaterials 32 13 2011 3435 3446
51. E. Frohlich The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles Int. J. Nanomed. 7 2012 5577 5591
52. C.S. Yah The toxicity of Gold Nanoparticles in relation to their physiochemical properties Biomed. Res.-India 24 3 2013 400 413
53. F. Wang, Z.L. Yang, L. Zhang, S.F. Weng, and J.G. Wu FT-IR study of the interaction between phosphatidylcholine and bovine serum albumin Acta Phys.-Chim. Sin. 20 10 2004 1186 1190
54. D. Krilov, M. Balarin, M. Kosovic, O. Gamulin, and J. Brnjas-Kraljevic FT-IR spectroscopy of lipoproteins -a comparative study Spectrochim. Acta Part A - Mole. Biomole. Spectros. 73 4 2009 701 706
55. Y. Li, S. Lim, and C.P. Ooi Fabrication of cisplatin-loaded poly(lactide-co-glycolide) composite microspheres for osteosarcoma treatment Pharm. Res. 29 3 2012 756 769
56. G. Scherphof, F. Roerdink, M. Waite, and J. Parks Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins Biochimica et Biophysica Acta 542 2 1978 296 307
57. P. Costa, and J.M. Sousa Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2 2001 123 133
58. I. El-Sayed, X. Huang, and M. El-Sayed Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles Cancer Lett. 239 1 2006 129 135
59. H.B. Frieboes, M. Wu, J. Lowengrub, P. Decuzzi, and V. Cristini A computational model for predicting nanoparticle accumulation in tumor vasculature PloS One 8 2 2013 e56876
60. H. Frieboes, J. Sinek, O. Nalcioglu, J. Fruehauf, and V. Cristini Nanotechnology in Cancer Drug Therapy: a biocomputational approach A. Lee, L.J. Lee, M. Ferrari, BioMEMS and Biomedical Nanotechnology 2006 Springer US 435 460
61. A.L. van de Ven, M. Wu, J. Lowengrub, S.R. McDougall, M.A. Chaplain, and V. Cristini Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors AIP Adv. 2 1 2012 11208
62. M. Wu, H.B. Frieboes, M.A. Chaplain, S.R. McDougall, V. Cristini, and J. Lowengrub The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems J. Theor. Biol. 355 2014 194 207